Leukocytapheresis as promising therapy for inflammatory bowel disease

被引：19
作者：
Caprilli, R. [1 ]
D'Ovidio, V. [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Clin Sci, GI Unit, Policlin Umberto I, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2007年 / 39卷 / 05期
关键词：
D O I：
10.1016/j.dld.2007.02.003
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：435 / 437
页数：3
相关论文
共 29 条
  • [11] Adsorptive monocyte-granulocytapheresis (M-GCAP) for refractory Crohn's disease
    Kusaka, T
    Fukunaga, K
    Ohnishi, K
    Kosaka, T
    Tomita, T
    Yokoyama, Y
    Sawada, K
    Fukuda, Y
    Miwa, H
    Matsumoto, T
    [J]. JOURNAL OF CLINICAL APHERESIS, 2004, 19 (04) : 168 - 173
  • [12] MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121
  • [13] INTERLEUKIN-13 INDUCES THE PRODUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) AND THE EXPRESSION OF THE MESSENGER-RNA FOR THE INTRACELLULAR (KERATINOCYTE) FORM OF IL-1RA IN HUMAN MYELOMONOCYTIC CELLS
    MUZIO, M
    RE, F
    SIRONI, M
    POLENTARUTTI, N
    MINTY, A
    CAPUT, D
    FERRARA, P
    MANTOVANI, A
    COLOTTA, F
    [J]. BLOOD, 1994, 83 (07) : 1738 - 1743
  • [14] Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis
    Naganuma, M
    Funakoshi, S
    Sakuraba, A
    Takagi, H
    Inoue, N
    Ogata, H
    Iwao, Y
    Ishi, H
    Hibi, T
    [J]. INFLAMMATORY BOWEL DISEASES, 2004, 10 (03) : 251 - 257
  • [15] Therapeutic efficacy of leukocytapheresis in a pregnant woman with severe active ulcerative colitis
    Okada, H.
    Makidono, C.
    Takenaka, R.
    Hiraoka, S.
    Fujiwara, A.
    Kato, J.
    Kawahara, Y.
    Kawamoto, H.
    Mizuno, M.
    Shiratori, Y.
    [J]. DIGESTION, 2006, 74 (01) : 15 - 18
  • [16] Rembacken B J, 1998, Ther Apher, V2, P93, DOI 10.1111/j.1744-9987.1998.tb00082.x
  • [17] Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis
    Sakimura, Kyoya
    Omori, Toshihide
    Iwashita, Etsuro
    Yoshida, Takeshi
    Tsuzuki, Yoshikazu
    Fujimori, Kenji
    Konishi, Fumio
    Yoshida, Yukio
    Anzai, Hiroo
    Suzuki, Hiromichi
    Sugawara, Souichi
    Takeda, Yuji
    Hiraishi, Katsuya
    Saniabadi, Abbi R.
    Ide, Tatsuo
    Miura, Soichiro
    Ota, Shinichi
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2006, 51 (09) : 1525 - 1531
  • [18] Pilot feasibility studies of leukocytapheresis with the adacolumn apheresis system in patients with active ulcerative colitis or Crohn disease
    Sands, Bruce E.
    Sandborn, William J.
    Wolf, Douglas C.
    Katz, Seymour
    Safdi, Michael
    Schwartz, David A.
    Hanauer, Stephen B.
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (06) : 482 - 489
  • [19] Leukocytapheresis in ulcerative colitis: Results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment
    Sawada, K
    Kusugami, K
    Suzuki, Y
    Bamba, T
    Munakata, A
    Hibi, T
    Shimoyama, T
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (06) : 1362 - 1369
  • [20] Leukocytapheresis (LCAP) for management of fulminant ulcerative colitis with toxic megacolon
    Sawada, K
    Egashira, A
    Ohnishi, K
    Fukunaga, K
    Kusaka, T
    Shimoyama, T
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (04) : 767 - 773
123